Effectiveness of Sphenopalatine Ganglion Block for Post-Dural Puncture Headache

Stopped early · Phase 2

Conditions studied: Post-Dural Puncture Headache, Sphenopalatine Ganglion Block

In brief

The objective of the study is to determine the effectiveness of Spheno-Palatine (SP) ganglion block to alleviate the pain of post-dural puncture headache (PDPH).

Key facts

Study ID

NCT03430531

Run by

Milton S. Hershey Medical Center

People needed

6

Starts

2019-05-31

Expected to finish

2022-03-11

Last updated by the study team

2022-06-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Complains of symptoms suggestive of post-dural puncture headache
• Has a history of dural puncture (lumbar puncture or accidental dural puncture during epidural placement) within the previous 7 days
• Fluent in written and spoken English

You may not qualify if…

• Those with a known history of hypersensitivity to local anesthetics of the amide type or to other components of GLYDO
• Those with any congenital or acquired, anatomical deformity of the nostril, which preclude performing the block
• Those who refuse to consent to participate in the study
• Patients who have had a failed epidural blood patch
• Cognitive Impairment
• Prisoner

Where it is running

• Milton S. Hershey Medical Center — Hershey, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.